Wednesday, August 26, 2026 1 PM-2 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology, and Molly Epler, MHI, LSSYB, Clinical Laboratory Manager, Wexner Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 23, 2026. 12 PM-12:30 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2026—Anchor Molecular launched its BCR-ABL1 control panels designed to support laboratories in monitoring the performance of the quantitative detection of BCR-ABL1 translocation mRNA transcripts.
June 2026—Bruker announced at ESCMID Global 2026 (Munich, April 17–21) portfolio enhancements to its MALDI Biotyper workflow. The proprietary MBT Easy T kit, available for research use only or CE-IVD marked under the EU IVDR, is designed to simplify and standardize sample transfer steps to MALDI target plates. It includes ready-to-use reagents and applicators, supporting up to 2,000 samples, and features room-temperature storage.
May 2026—The Food and Drug Administration granted 510(k) clearance to Roche’s Cobas c 703 and Cobas ISE Neo analytical units.
May 2026—Streck released MDx-Chex for RLP, a ready-to-use, full-process molecular quality control designed for respiratory low-plex assay verification.
May 2026—The Diagnostic Medicine Consortium and Virchow Medical have formed a partnership aimed at expanding longitudinal, evidence-based cancer therapy to more patients.
May 2026—The FDA has approved Grifols’ Procleix Plasmodium assay for screening blood donors for malaria.
May 2026—The Food and Drug Administration has cleared the Qiagen QIAstat-Dx Gastrointestinal Panel 2 and QIAstat-Dx GI Panel 2 Mini B and Mini B&V for use on the QIAstat-Dx Rise automated syndromic testing system.
May 2026—Bruker’s microbiology and infection diagnostics division launched at ESCMID Global (April 17–21, Munich) the MyGenius Pro system in Europe.
May 2026—Sarstedt’s Tempus1800 sample transport system was awarded a Vizient innovative technology contract.
May 2026—City of Hope is implementing Quest Diagnostics’ Haystack MRD, a circulating-tumor DNA minimal residual disease test, for clinical trial patients with solid tumor cancers to help guide disease management for breast, colorectal, ovarian, and prostate cancer.
